Neuroblastoma cell lines display heterogeneity in differentiation responses
Wellcome Open Research · 16.09.2025 · 9 · 671
DOI: 10.12688/wellcomeopenres.23249.2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Wellcome Open Research, online erschienen am 16.09.2025. Verfasst von Kirsty M Ferguson und 4 weiteren Autor:innen. Beteiligte Einrichtung: Jeffrey Cheah Biomedical Centre, Cambridge Stem Cell Institute, Cambridge, England, CB2 0AW, UK. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Medical Research Council, Cancer Research UK.
Abstract (Originalsprache)
Background
Neuroblastoma is the most common extra-cranial childhood solid tumour, arising during development from stalled neural crest-derived precursor cells. In a subset of children younger than 18 months of age, neuroblastoma can undergo spontaneous regression driven by differentiation, leading to great interest in developing differentiation therapies to re-direct neuroblastoma cells down their correct developmental pathway. Recently, we have shown that combinatorial treatment with the CDK4/6 inhibitor palbociclib and differentiation-inducing agent retinoic acid inhibits proliferation and drives neuronal differentiation of adrenergic-type neuroblastoma cell lines.
Methods
Here, we explore the differentiation potential of neuroblastoma cell lines in vitro in response to palbociclib and retinoic acid treatment using microscopy, transcriptomic and qRT-PCR analyses.
Results
We present evidence suggesting that neuroblastoma cells can give rise to mixtures of neural crest-derived adrenal gland cell types, and that differentiation responses correspond to changes in patterns of extracellular matrix substrate expression.
Conclusions
This study builds a case to further investigate and consider heterogeneity in neuroblastoma cell differentiation and extracellular matrix changes during these cell fate decisions.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Jeffrey Cheah Biomedical Centre, Cambridge Stem Cell Institute, Cambridge, England, CB2 0AW, UK.
- Cambridge University Hospitals NHS Foundation Trust, Cambridge, England, UK.
- University of Cambridge Department of Paediatrics, Cambridge, England, CB2 0XZ, UK.
- University of Cambridge Department of Oncology, Cambridge, England, CB2 0XZ, UK.
ORCID-Profile: Kirsty M Ferguson, Fiona M Y Abou Grealy
Förderung
- Wellcome Trust
- Medical Research Council
- Cancer Research UK
Zitieren
APA
Ferguson, K. M., Gillen, S. L., Abou Grealy, F. M. Y., Vedi, A., & Philpott, A. (2025). Neuroblastoma cell lines display heterogeneity in differentiation responses. Wellcome Open Research, 9, 671. https://doi.org/10.12688/wellcomeopenres.23249.2
Vancouver
Ferguson KM, Gillen SL, Abou Grealy FMY, Vedi A, Philpott A. Neuroblastoma cell lines display heterogeneity in differentiation responses. Wellcome Open Research. 2025;9:671. doi:10.12688/wellcomeopenres.23249.2
BibTeX
@article{Ferguson2025,
author = {Ferguson, Kirsty M and Gillen, Sarah L and Abou Grealy, Fiona M Y and Vedi, Aditi and Philpott, Anna},
title = {Neuroblastoma cell lines display heterogeneity in differentiation responses},
journal = {Wellcome Open Research},
year = {2025},
volume = {9},
pages = {671},
doi = {10.12688/wellcomeopenres.23249.2}
}
EUVIMED